Tirzépatide significantly improves the lipid profile: lowering LDL, reducing triglycerides, and increasing HDL.
Impact of Tirzépatide on LDL Cholestérol
Tirzépatide reduces LDL-cholestérol by 5 to 10% on average in clinical trials. Although this reduction is modest compared to statins, it adds to the effects of the latter. In patients already on statins, tirzépatide provides an additional improvement in the lipid profile. Weight loss and improved insulin resistance contribute to this improvement.
The Dramatic Effect on Triglycerides
The reduction in triglycerides is one of the most pronounced effects of tirzépatide on the lipid profile: -25 to -35% in SURMOUNT trials. Elevated triglycerides (>1.5 g/L) are an independent cardiovascular risk factor and a criterion for metabolic syndrome. This reduction is linked to visceral fat loss and improved insulin sensitivity, which reduces hepatic VLDL (triglyceride precursor) production.
When to Recheck a Lipid Panel While on Tirzépatide
A baseline lipid panel should be performed before starting treatment, then repeated at 3 and 6 months. If the results are satisfactory, an annual check-up is sufficient thereafter. Patients on statins may have their doctor adjust the statin dosage based on the lipid improvement achieved with tirzépatide. The LDL target depends on the individual’s cardiovascular risk level.
Track your progress with the MounjaGO app.
FAQ
What are the main recommendations for tirzépatide under GLP-1 treatment?
Key recommendations include regular medical follow-ups, monitoring blood tests, adequate protein intake, and adapted physical activity. Consult your doctor for personalized advice for your situation.
Is tirzépatide (Mounjaro) effective for lipid profile?
The SURMOUNT and SURPASS clinical trials have demonstrated the efficacy of tirzépatide in this indication, with significant documented results. Your doctor will evaluate the relevance of the treatment for your individual profile.
What side effects should be monitored in relation to tirzépatide?
Side effects to monitor depend on your personal situation. The most common are gastrointestinal disturbances (nausea, diarrhea, constipation). Report any unusual symptoms to your doctor for évaluation.
How does the MounjaGO app help with tirzépatide?
MounjaGO offers comprehensive tracking of injections, weight, side effects, and generates PDF reports for your consultations. This structured monitoring improves therapeutic adherence and communication with your doctor.